NCT04173949View on ClinicalTrials.gov

Explorative Study for Treating Persistent Developmental Stuttering With Ramipril

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Persistent Developmental Stuttering
Interventions
DRUG

Ramipril 2.5 MG

3 month of treatment with daily Ramipril 2.5 MG

Trial Locations (2)

Unknown

Haemek Medical Center, Afula

Asaf Harophe, Tzrifin

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT04173949 - Explorative Study for Treating Persistent Developmental Stuttering With Ramipril | Biotech Hunter | Biotech Hunter